Advances in genome sequence have enabled rapid identification of new SARS-CoV-2 variant lineages, but a major challenge is understanding how mutations in these variants will affect anti-viral immunity. Here I describe new high-throughput assays that provide data that can be used to rapidly interpret the consequences of SARS-CoV-2 mutations.